MedicaidMay 28, 2025
Clinical Criteria updates
Effective August 29, 2025
Summary: The Pharmacy and Therapeutics (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.
Visit our Clinical Criteria page to find specific policies. For questions or additional information, email Druglist@carelon.com.
See the explanation/definition for each category of Clinical Criteria below:
- New: newly published criteria
- Revised: addition or removal of medical necessity requirements, new document number
Please share this notice with other members of your practice and office staff.
Note:
- The Clinical Criteria listed below apply only to the medical drug benefits contained within the member’s medical plan. This does not apply to pharmacy services.
- This notice is meant to provide information on new or revised criteria that have been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | Status |
August 29, 2025 | CC-0282 | Onapgo (apomorphine subcutaneous solution) | New |
August 29, 2025 | CC-0149 | Select Clotting Agents for Bleeding Disorders | Revised |
August 29, 2025 | CC-0037 | Kanuma (sebelipase alfa) | Revised |
August 29, 2025 | CC-0159 | Scenesse (afamelanotide) | Revised |
August 29, 2025 | CC-0245 | Izervay (avacincaptad pegol) | Revised |
August 29, 2025 | CC-0197 | Jemperli (dostarlimab-gxly) | Revised |
August 29, 2025 | CC-0106 | Erbitux (cetuximab) | Revised |
August 29, 2025 | CC-0027 | Denosumab | Revised |
August 29, 2025 | CC-0066 | Monoclonal Antibodies to Interleukin-6 | Revised |
August 29, 2025 | CC-0002 | Colony Stimulating Factor Agents | Revised |
August 29, 2025 | CC-0078 | Orencia (abatacept) | Revised |
CarelonRx, Inc. is a separate company providing utilization review services on behalf of the health plan.
Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
CABC-CD-083827-25, CPN83640
To view this article online:
Visit https://providernews.anthem.com/california/articles/clinical-criteria-updates-25479
Or scan this QR code with your phone